Passionflower for Sleep: Human Trials, Insomnia Evidence, and Limits
What the evidence actually shows
Evidence LimitedDirect answer
Evidence review of Passiflora incarnata for sleep, including the polysomnography insomnia trial, tea study, 2024 standardized-extract RCT, and 2025 OTC insomnia review. Passionflower has direct randomized human sleep research, including a 110-person insomnia trial with polysomnography. The strongest objective signal in that trial was about 23 minutes more total sleep time versus essentially no change with placebo; sleep efficiency and WASO did not separate significantly from placebo. A small tea study found better subjective sleep quality, while a 2024 standardized-extract trial reported improvements in stress and sleep outcomes.
Research brief
Questions this page answers
- Does passionflower help insomnia?
- What does the passionflower polysomnography trial show?
- Does passionflower tea improve sleep?
- How strong is the evidence for Passiflora incarnata and sleep?
Signal
Scientific takeaways
- Passionflower has direct randomized human sleep research, including a 110-person insomnia trial with polysomnography.
- The strongest objective signal in that trial was about 23 minutes more total sleep time versus essentially no change with placebo; sleep efficiency and WASO did not separate significantly from placebo.
- A small tea study found better subjective sleep quality, while a 2024 standardized-extract trial reported improvements in stress and sleep outcomes.
- Different Passiflora preparations should not be treated as interchangeable, and the overall evidence remains limited rather than definitive.
Bottom line: Passionflower is not just a traditional-sedative story. It has randomized human sleep trials, including a relatively substantial insomnia study that used overnight polysomnography. The signal is promising but limited: total sleep time improved in the strongest direct trial, while several other objective outcomes did not clearly separate from placebo. Tea, extract, and multi-herb products should not be treated as the same intervention.
The most important trial used polysomnography in adults with insomnia
A double-blind randomized placebo-controlled study enrolled 110 adults with DSM-5 insomnia disorder and tested Passiflora incarnata extract for two weeks.[1] Participants underwent overnight polysomnography and also completed sleep diaries, the Insomnia Severity Index, and the Pittsburgh Sleep Quality Index.
The clearest between-group result was total sleep time. The passionflower group increased total sleep time by about 23 minutes, compared with essentially no change in the placebo group. That result reached statistical significance.
This is stronger evidence than a simple pre/post questionnaire change because the study included both placebo control and an objective sleep measurement.
But the full endpoint pattern matters. Sleep efficiency and wake after sleep onset improved within the passionflower group, yet those changes did not significantly differ from placebo. That means the trial should not be summarized as “passionflower improved every major sleep parameter.”
A more accurate statement is: passionflower produced a modest placebo-separated improvement in total sleep time in this short-term insomnia trial, while evidence for other objective endpoints was weaker.
Why the 23-minute result is more useful than a generic “sleep improved” claim
Sleep studies often compress multiple outcomes into one headline. That is especially risky here.
Total sleep time asks how long someone slept. Sleep efficiency asks what proportion of time in bed was actually spent asleep. Wake after sleep onset measures how much time a person spent awake after initially falling asleep. Sleep-onset latency asks how long falling asleep took.
An intervention can improve one without improving the others.
The passionflower insomnia trial is a good example of why endpoint-level reporting matters: the strongest direct evidence is for total sleep time, not a universal improvement in sleep architecture or insomnia severity.
The tea study found a subjective sleep-quality signal
A 2011 double-blind placebo-controlled crossover study tested passionflower herbal tea in 41 healthy adults ages 18 to 35.[2] Participants consumed passionflower or placebo tea for one week per condition and completed sleep diaries. Ten participants also underwent polysomnography.
Of six sleep-diary measures analyzed, subjective sleep quality was significantly better with passionflower tea than placebo.
That finding is useful, but it should stay in its lane. The participants did not represent a large chronic-insomnia population, the treatment period was short, and the PSG subgroup was tiny. The study supports a short-term subjective sleep-quality effect; it does not prove that passionflower tea reliably treats insomnia disorder.
A newer 2024 trial adds another positive signal
A 2024 randomized double-blind placebo-controlled trial enrolled 65 participants with stress and sleep problems and tested a standardized Passiflora incarnata extract for 30 days.[3]
The trial reported improvements in perceived stress, psychological health, and sleep-related outcomes, including total sleep time, compared with placebo.
This broadens the evidence base beyond the older tea study and the 2020 insomnia trial. It also introduces another formulation problem: a standardized commercial extract cannot automatically validate every passionflower capsule, tincture, tea, or blended product.
The trial also enrolled people with both stress and sleep problems. If stress improves at the same time as sleep, the mechanism may involve reduced arousal rather than a direct hypnotic effect. That is clinically interesting, but it is not the same claim as “passionflower acts like a sleeping pill.”
The 2025 OTC insomnia review is encouraging but not definitive
A 2025 scoping review mapped 51 randomized controlled trials of over-the-counter products for adult insomnia.[4] Herbal interventions were common, and the authors described several products and combinations as promising.
The overall conclusion, however, was still promising but inconclusive. The studies varied in formulation, population, sample size, co-morbidities, comparators, and outcome definitions.
Passionflower also appears in some multi-herb combinations. Those trials cannot isolate how much benefit came from passionflower itself. A valerian-hops-passionflower combination is evidence for that combination, not automatically for each ingredient alone.
Formulation is one of the biggest uncertainties
The human literature includes passionflower as:
- herbal tea;
- standardized extract;
- standalone botanical intervention; and
- part of multi-ingredient herbal combinations.
Those are not interchangeable.
Plant species, extraction solvent, plant part, standardization, active-constituent profile, manufacturing quality, and delivered amount can all differ. Even when two labels both say Passiflora incarnata, the exposure may not match the preparation used in a positive trial.
This is why a supplement listing “passionflower 500 mg” cannot inherit a clinical effect size unless its preparation is meaningfully comparable to the studied intervention.
Does passionflower help you fall asleep or stay asleep?
The current evidence does not support a clean one-line answer.
The strongest insomnia trial supports a total-sleep-time effect. The tea study supports subjective sleep quality. The 2024 trial supports a broader stress-and-sleep signal. Evidence is much thinner for claiming a dependable reduction in sleep-onset latency, a specific effect on nighttime awakenings, or a consistent change in sleep stages.
So the best summary is not “passionflower is for sleep onset” or “passionflower is for sleep maintenance.” The evidence is too small and heterogeneous to assign it confidently to one insomnia phenotype.
Is passionflower a proven treatment for chronic insomnia?
No.
There is more direct human evidence than many supplement summaries imply, but the evidence base remains small compared with established insomnia treatments. Trials are short, formulations differ, and several clinically important endpoints remain uncertain.
Persistent insomnia should also trigger consideration of sleep apnea, restless legs, circadian delay, insufficient sleep opportunity, medication effects, substance use, pain, mood disorders, and behavioral insomnia mechanisms. Cognitive behavioral therapy for insomnia remains the evidence-based first-line benchmark for chronic insomnia.
Safety and practical interpretation
Passionflower is generally treated as a calming or sedating botanical, so additive drowsiness is a sensible concern when it is combined with alcohol, sedating medicines, or other sleep aids. Product quality also matters because concentrated extracts and combination products vary substantially.
Pregnancy, breastfeeding, major medical conditions, and prescription-drug use are situations where individualized professional review is appropriate before using concentrated herbal products.
The evidence supports viewing passionflower as a reasonable but low-certainty sleep experiment, not as a substitute for evaluating persistent or severe insomnia.
Bottom line
Passionflower has a real human sleep evidence base. The best direct insomnia trial found roughly 23 minutes more total sleep time with passionflower than placebo over two weeks, while several other objective endpoints did not clearly separate from placebo.[1] A tea study found better subjective sleep quality,[2] and a newer standardized-extract RCT adds another positive signal in people with stress and sleep problems.[3]
That is enough to take passionflower seriously. It is not enough to call it proven.
The most defensible verdict is limited evidence with a plausible short-term benefit, strongest for selected sleep outcomes and still highly dependent on formulation and population.
Related reading
Source ledger
References
4 sources
- 01Effects of Passiflora incarnata Linnaeus on polysomnographic sleep parameters in subjects with insomnia disorder: a double-blind randomized placebo-controlled study Lee J, Jung HY, Lee SI, Choi JH, Kim SG · 2020 PubMed →
- 02A double-blind, placebo-controlled investigation of the effects of Passiflora incarnata herbal tea on subjective sleep quality Ngan A, Conduit R · 2011 PubMed →
- 03Randomized, Double-Blind, Placebo-Controlled, Clinical Study of Passiflora incarnata in Participants With Stress and Sleep Problems Randomized placebo-controlled trial · 2024 PubMed →
- 04Over-the-counter products for insomnia in adults: A scoping review of randomised controlled trials Scoping review of randomized controlled trials · 2025 PubMed →